Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention

Objective:Universal eligibility for lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women (’Option B+’) has been widely adopted, but concerns remain. We tested the hypothesis that the change from CD4+-guided ART eligibility (’Option A’), to Option B+, would improve maternal ART